Allergic conjunctivitis from an allergen-driven Th2 response is characterized by conjunctival eosinophilic infiltration.
CCR6 KO mice were significantly protected from EAC and neutralization of CCL20 inhibits the development of EAC.
Neutralization of CCR6 ligand, CCL20 inhibits the development of experimental allergic conjunctivitis.